Home Health Care Coming up on Day 2 of MedCity INVEST Precision Medicine

Coming up on Day 2 of MedCity INVEST Precision Medicine

12
0
SHARE

The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and life science executives and investors as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug development, and reimbursement models for cell and gene therapy.

To view the full agenda, click here.

Here’s what’s happening on Day 2 of the conference:

10am-11:30am ET Health IT track of the startup pitch competition Pitch Perfect

Each startup will have four minutes to present their companies and six minutes to answer questions from judges.

Backdrop Health, Inc. has created novel machine-learning and AI software that maximizes the value of electronic medical records, enabling a new level of precision predictive medicine. Backdrop’s solution radically extends the established concept of comorbidity (the occurrence of more than one condition in a patient at a time, such as obesity and diabetes). Given any body of medical records our software creates the backdrop for those records. A backdrop is a rich and comprehensive knowledge graph that captures the relationship of every clinical and demographic factor to every other factor. Querying the backdrop can bring massive benefits to clinical trials of new drugs, making it easier for pharmaceutical companies to bring new therapies to market, and to all aspects of personalized medicine, enabling health care providers to preemptively identify health issues and improve patient outcomes. Backdrop Health was launched in 2020 to commercialize this mature technology developed over four years at The University of Utah.

CEO: Jerry Rudisin

Headquarters: Salt Lake City, UT

Destroke is a digital health company developing a mobile app for automated clinical stroke detection.  This app uses speech, face, and motion recognition technologies to detect the signs of stroke, based on the validated NIH stroke scale, and can report these findings to patients, loved ones, telestroke providers, healthcare providers, and EMS.  This app is intended to be used by those at risk for stroke, such as patients who have had a stroke or those with cardiovascular risk factors, as well as healthcare providers who may not have expertise in stroke detection.

CEO: Evan Noch, MD

Headquarters: New York, NY

DrugViu’s digital platform makes medical research more inclusive and accessible by making it easy for diverse people living with autoimmune diseases to contribute their clinical grade data to research and participate in clinical research.

CEO: Kwaku Owusu

Headquarters: New York, NY

Parallel Profile is on a mission to save lives and billions in wasted healthcare spending by preventing adverse drug reactions.

CEO: Cathy Cather

Headquarters: Fort Lauderdale, FL

Siris Medical

Because oncology is so complex, treatments are highly patient-specific, and outcomes are heavily dependent on clinician expertise and experience. This complexity is even more challenging for healthcare payers, which have limited clinical information to judge value for treatment authorization. These challenges can cause treatment delays and subpar care. Siris Medical’s AI-driven decision-support software solves these challenges simultaneously by providing high-quality care insights for clinicians, while automating prior authorization, leveraging a massive, expert library of over 25,000 patient treatments integrated into clinical workflow.

CEO: Colin Carpenter, PhD

Headquarters: Burlingame, CA and Boston, MA

Judges:

Siddarth Sridhar is a corporate development associate with Centene’s global M&A group.

Aron Starosta is VP of Commercialization and New Ventures, University City Science Center.

1-2PM ET Interoperability Progress Report
How far have we progressed with sharing patient medical records? Patient data is key in unlocking riddles of medical science but interoperability is necessary to facilitate this. What companies are making an impact on a regional and national scale? What milestones are on the horizon? What obstacles continue to vex further advancement? How can we make medical records more accessible to patients?

Moderator: Elise Reuter, Senior Reporter, MedCity News
Speakers:
Kevin Chaney, Senior Program Manager, Office of the National Coordinator for Health IT
Ida Sim, M.D., Ph.D., Professor of Medicine, University of California, San Francisco
Niko Skievaski, Co-Founder and President, Redox

4–5 PM ET
Venture Cafe Virtual Session: What It Takes To Build A Successful, Regional BioInnovation Hub
Philadelphia is one of many cities seeking to support the continued growth of cell and gene therapy and connected health industries. What do cities need to do to address education, training and other needs to support these sectors? This session will be held as part of Venture Cafe Philadelphia.

sponsored by IBX

Moderator: Michelle Histand, Director of Innovation, Independence Blue Cross
Speakers:
Lisa Dalton, CPO, Spark Therapeutics
Audrey Greenberg, Co-Founder, The Discovery Labs
Tiffany Wilson, President & CEO, University City Science Center

5PM Venture Café Philadelphia Networking Event
Join MedCity News at Venture Café Philadelphia powered by the University City Science Center.

Photo: Getty Images

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

nine + thirteen =